Tyrosine kinase inhibitors - PDFSEARCH.IO - Document Search Engine

Tyrosine kinase inhibitors
Results: 62

#	Item
31	Fragment based drug discovery of orally selective inhibitors of Fibroblast Growth Factor Receptor (FGFr) G Saxty, V Berdini, M G Carr, A Cleasby, J Coyle , L Fazal, R Feltell, C Griffiths-Jones, B Graham, I Harada, E J L Add to Reading List Source URL: astx.com Language: English Growth factors Fibroblast growth factor receptor Fibroblast growth factor VEGF receptors Vascular endothelial growth factor Biology Tyrosine kinase receptors Cell biology
32	Honours Projects 2014 – Pharmacology Pharmacogenomics and pharmacokinetics of tyrosine kinase inhibitors in leukaemia Project Background Several pharmacogenomic studies are likely to be offered for 2013 in Add to Reading List Source URL: health.adelaide.edu.au Language: English - Date: 2013-09-25 02:05:52 Organic chemistry Chemistry Medicine Piperazines Orphan drugs Tyrosine-kinase inhibitor Nilotinib Chronic myelogenous leukemia Imatinib Pyrimidines Pyridines Pharmacy
33	Combining the HSP90 inhibitor, AT13387, with vemurafenib delays the emergence of V600E resistance in a preclinical model of BRAF mutant melanoma. Tomoko Smyth, Jon Lewis, Keisha Hearn, Neil Thompson, John Lyons, Mohammad Add to Reading List Source URL: astx.com Language: English - Date: 2013-09-21 15:10:26 Chemistry Tyrosine kinase inhibitors Organochlorides Organofluorides Sulfonamides Vemurafenib BRAF Hsp90 Melanoma Medicine Biology Oncogenes
34	Fragment Based Drug Discovery of Selective Inhibitors of Fibroblast Growth Factor Receptor (FGFR[removed]G. Saxty1, R. Akkari2, P. Angibaud2, J. Arts2, P. Benderitter2, V. Berdini1, P. Bonnet2, A. Cleasby1, I. Csoka2, W. E Add to Reading List Source URL: astx.com Language: English Tyrosine kinase receptors Protein domains Fibroblast growth factor receptor FLT3LG Tyrosine kinase Fibroblast growth factor CD135 Protein kinase Biology Cell signaling Cell biology
35	Development of Inhibitors of the Fibroblast Growth Factor Receptor (FGFR) Kinase Using a Fragment Based Approach Poster: 3626 M S Squires, T Perera$, G Saxty, C W Murray, P King$, G A Ward, R Feltell, S Rich, P Angibaud$ Add to Reading List Source URL: astx.com Language: English Fibroblast growth factor Tyrosine kinase Protein kinase inhibitor Protein kinase IC50 Receptor tyrosine kinase Tyrosine kinase receptors Biology Cell biology
36	Development of Inhibitors of the Fibroblast Growth Factor Receptor (FGFR) Kinase Using a Fragment Based Approach[removed]M S Squires, G Saxty, C W Murray, V Berdini, G A Ward, M Batey, A Peasland,D Miller, S J Rich, A C Add to Reading List Source URL: astx.com Language: English - Date: 2012-12-13 18:06:00 Hematologic neoplasms Protein domains Fibroblast growth factor Morphogens Multiple myeloma Biology Tyrosine kinase receptors Cell biology
37	Drug Monitoring Symposium Swiss MedLab 2012 Therapeutic Drug Monitoring of Tyrosine Kinase Inhibitors Add to Reading List Source URL: www.sulm.ch Language: English - Date: 2013-10-23 12:25:48 Pyrimidines Amines Pyridines Orphan drugs Protein kinase inhibitor Tyrosine-kinase inhibitor Imatinib Chronic myelogenous leukemia Dasatinib Chemistry Organic chemistry Organofluorides
38	A Novel Homogenous, Rapid, Non-Radioactive and High-Throughput Formatted Assay System for Protein Kinases and Phosphatases Scientific Poster, PS051 Add to Reading List Source URL: www.promega.com Language: English - Date: 2011-01-21 11:31:33 Protein kinase Phosphatase PP2 AKT Tyrosine kinase Protein phosphatase 1 Protease Biology Molecular biology Protein kinase inhibitors Chemistry Protein kinases
39	Assay Optimization and Profiling in uHTS Format Scientific Poster, PS027 Add to Reading List Source URL: www.promega.com Language: English - Date: 2011-01-21 11:31:32 Organochlorides PP2 Pyrazolopyrimidines Wortmannin Tyrosine kinase IC50 Phosphoinositide 3-kinase Chemistry Protein kinase inhibitors Organic chemistry
40	AMBIT BIOSCIENCES AND ASTELLAS ENTER STRATEGIC PARTNERSHIP TO RESEARCH, DEVELOP AND COMMERCIALIZE FLT3 KINASE INHIBITORS IN MULTIPLE INDICATIONS Ambit to Receive a $40 Million Upfront Cash Payment; Up to $350 Million Add to Reading List Source URL: www.astellas.com Language: English - Date: 2009-12-17 23:42:07 Cell signaling CD135 Acute myeloid leukemia Organic chemistry Quizartinib Tyrosine kinase Astellas Pharma Leukemia Lestaurtinib Oncology Acute leukemia Myeloid leukemia